Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$11.56 - $19.76 $348,730 - $596,099
-30,167 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$11.18 - $15.46 $100 - $139
9 Added 0.03%
30,167 $418,000
Q3 2021

Nov 04, 2021

SELL
$14.21 - $17.65 $31,645 - $39,306
-2,227 Reduced 6.88%
30,158 $433,000
Q2 2021

Aug 05, 2021

BUY
$9.5 - $17.24 $73,615 - $133,592
7,749 Added 31.45%
32,385 $512,000
Q1 2021

May 07, 2021

BUY
$7.37 - $13.61 $95,375 - $176,127
12,941 Added 110.65%
24,636 $318,000
Q4 2020

Jan 13, 2021

BUY
$3.37 - $8.61 $11,215 - $28,654
3,328 Added 39.78%
11,695 $87,000
Q3 2020

Nov 12, 2020

BUY
$3.43 - $5.53 $24,637 - $39,721
7,183 Added 606.67%
8,367 $29,000
Q2 2020

Aug 13, 2020

BUY
$1.9 - $5.61 $2,249 - $6,642
1,184 New
1,184 $6,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.45B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.